Results 271 to 280 of about 254,141 (317)
Some of the next articles are maybe not open access.

Glucocorticoids and Osteoporosis

Endocrinology and Metabolism Clinics of North America, 1994
In summary, patients who will remain on glucocorticoids for more than a few weeks are clearly at risk for osteoporosis. A list of therapeutic strategies is provided in Table 2. While our therapy remains inadequate at this time, newer agents are on the horizon.
R A, Adler, C J, Rosen
openaire   +2 more sources

Glucocorticoids and Asthma

2002
Corticosteroids are highly effective anti-inflammatory therapy in asthma, and the molecular mechanisms involved in suppression of allergic inflammation are now better understood (Barnes 1998, 2001). Corticosteroids are effective clinically because they block many of the inflammatory pathways that are abnormally activated in asthma and they have a very ...
openaire   +2 more sources

Glucocorticoids for croup

2004
Since the initial version of this systematic review in 1997, a number of randomised trials examining the benefit of glucocorticoids have been published, reflecting a continued interest in the use of glucocorticoids to treat patients with croup. The objective of this review was to provide evidence to guide clinicians in their treatment of patients with ...
K, Russell   +6 more
openaire   +2 more sources

Glucocorticoid Resistance

2010
Changes in glucocorticoid (GC) receptor sensitivity can be categorized in three different types. First, generalized GC resistance syndrome is a hereditary disease. Patients present with signs and symptoms of increased androgen and/or mineralocorticoid action, combined with biochemical hypercortisolism, but lack of cushingoid features.
E F C, van Rossum, E L T, van den Akker
openaire   +5 more sources

Glucocorticoid Osteoporosis

Current Pharmaceutical Design, 2002
Postmenopausal women are at greatest risk of rapid bone loss and fracture with glucocorticoids and should be actively considered for prophylactic measures. In men and premenopausal women receiving glucocorticoids, the decision to use anti-osteoporosis prophylaxis is less clear and depends upon baseline bone mineral density [BMD], anticipated dose and ...
openaire   +2 more sources

Designer glucocorticoids

Biochemical Pharmacology, 2002
Glucocorticoids are the most effective anti-inflammatory agents known. However, the use of these powerful molecules is plagued by a host of serious, sometimes life-threatening side-effects. The search for new compounds that maintain the efficacy of the steroids without some of the side-effects has entered a new phase.
openaire   +2 more sources

Glucocorticoids for croup

Cochrane Database of Systematic Reviews, 2011
Since the initial publication of this systematic review in 1997, several randomized trials examining the benefit of glucocorticoids have been published. The objective of this review is to provide evidence to guide clinicians in their treatment of patients with croup by determining the effectiveness of glucocorticoids and to identify areas requiring ...
Kelly F, Russell   +4 more
openaire   +2 more sources

Glucocorticoids and the Lung

2015
The lung is a major clinical target of glucocorticoid-based therapeutics, and GR signaling has broad effects on respiratory physiology and inflammation. During lung development, expression of GR in the mesenchyme is required for normal terminal alveolar epithelial differentiation.
openaire   +2 more sources

Glucocorticoids for croup

1999
Since the last meta-analysis in 1989, a number of randomised trials on the benefit of glucocorticoids have been published, resulting in an increasing interest in the use of glucocorticoids to treat outpatients with croup. The objective of this review was to provide evidence to guide clinicians in their treatment of patients with croup, to examine the ...
M, Ausejo   +6 more
openaire   +2 more sources

Glucocorticoids

Acta Paediatrica, 1994
A, Greenough, B, Yüksel
openaire   +2 more sources

Home - About - Disclaimer - Privacy